Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2015 | 4.91 Million USD | -48.6% |
| 2014 | 9.56 Million USD | 741.88% |
| 2013 | 1.13 Million USD | 1254.33% |
| 2012 | 83.91 Thousand USD | -65.17% |
| 2011 | 240.92 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 716.85 Thousand USD | 0.0% |
| 2005 | 716.85 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2015 FY | 4.91 Million USD | -48.6% |
| 2015 Q1 | 10.83 Million USD | 13.28% |
| 2014 FY | 9.56 Million USD | 741.88% |
| 2014 Q1 | 116.15 Thousand USD | -89.78% |
| 2014 Q2 | 1.59 Million USD | 1273.19% |
| 2014 Q3 | 9.56 Million USD | 499.64% |
| 2014 Q4 | 9.56 Million USD | 0.03% |
| 2013 Q1 | 1.05 Million USD | 1155.04% |
| 2013 Q4 | 1.13 Million USD | -1.68% |
| 2013 FY | 1.13 Million USD | 1254.33% |
| 2013 Q2 | 1.18 Million USD | 12.44% |
| 2013 Q3 | 1.15 Million USD | -2.39% |
| 2012 Q4 | 83.91 Thousand USD | -31.23% |
| 2012 Q2 | 163.19 Thousand USD | -19.76% |
| 2012 Q1 | 203.37 Thousand USD | -15.59% |
| 2012 FY | 83.91 Thousand USD | -65.17% |
| 2012 Q3 | 122.02 Thousand USD | -25.23% |
| 2011 FY | 240.92 Thousand USD | 0.0% |
| 2011 Q4 | 240.92 Thousand USD | 6.2% |
| 2011 Q3 | 226.85 Thousand USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q1 | 716.85 Thousand USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | 716.85 Thousand USD | 0.0% |
| 2006 Q4 | 716.85 Thousand USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 FY | 716.85 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -81866.667% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -279.033% |
| Biocept, Inc. | 10.37 Million USD | 52.598% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 90.415% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 91.967% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -800.198% |
| iMD Companies, Inc. | 1.1 Million USD | -345.606% |
| IDenta Corp. | 428.17 Thousand USD | -1048.593% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -15.909% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -1669.065% |
| NovelStem International Corp. | 3.32 Million USD | -47.928% |
| Optigenex Inc. | 4.42 Million USD | -11.089% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -201.533% |
| Rennova Health, Inc. | 359.19 Thousand USD | -1269.18% |
| RushNet, Inc. | 4.25 Million USD | -15.653% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -1874.704% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -515.95% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -753.254% |
| Todos Medical Ltd. | 33 Million USD | 85.097% |